Entity Details

Primary name GDAP1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ8TB36
EntryNameGDAP1_HUMAN
FullNameGanglioside-induced differentiation-associated protein 1
TaxID9606
Evidenceevidence at protein level
Length358
SequenceStatuscomplete
DateCreated2003-11-07
DateModified2021-06-02

Ontological Relatives

GenesGDAP1

GO terms

Show/Hide Table
GOName
GO:0000266 mitochondrial fission
GO:0005634 nucleus
GO:0005739 mitochondrion
GO:0005778 peroxisomal membrane
GO:0005829 cytosol
GO:0006626 protein targeting to mitochondrion
GO:0006749 glutathione metabolic process
GO:0008053 mitochondrial fusion
GO:0016020 membrane
GO:0031307 integral component of mitochondrial outer membrane
GO:0045046 protein import into peroxisome membrane

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Mitochondrion outer membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR004045 Glutathione S-transferase, N-terminalDomainDomain
IPR010987 Glutathione S-transferase, C-terminal-likeDomainDomain
IPR034336 Ganglioside-induced differentiation-associated protein 1FamilyFamily
IPR036249 Thioredoxin-like superfamilyFamilyHomologous superfamily
IPR036282 Glutathione S-transferase, C-terminal domain superfamilyFamilyHomologous superfamily
IPR040079 Glutathione Transferase familyFamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
607831 OMIMCharcot-Marie-Tooth disease 2K (CMT2K)An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Charcot-Marie-Tooth disease type 2K onset is in early childhood (younger than 3 years). This phenotype is characterized by foot deformities, kyphoscoliosis, distal limb muscle weakness and atrophy, areflexia, and diminished sensation in the lower limbs. Weakness in the upper limbs is observed in the first decade, with clawing of the fingers. Inheritance can be autosomal dominant or recessive. The disease is caused by variants affecting the gene represented in this entry.
607706 OMIMCharcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive (CMT2RV)A form of Charcot-Marie-Tooth disease characterized by the association of axonal neuropathy with vocal cord paresis. Charcot-Marie-Tooth disease is a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. The disease is caused by variants affecting the gene represented in this entry.
608340 OMIMCharcot-Marie-Tooth disease, recessive, intermediate type, A (CMTRIA)A form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Recessive intermediate forms of Charcot-Marie-Tooth disease are characterized by clinical and pathologic features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec. The disease is caused by variants affecting the gene represented in this entry.
214400 OMIMCharcot-Marie-Tooth disease 4A (CMT4A)A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. CMT4A is a severe form characterized by early age of onset and rapid progression leading to inability to walk in late childhood or adolescence. The disease is caused by variants affecting the gene represented in this entry.

Interactions

42 interactions

InteractorPartnerSourcesPublicationsLink
GDAP1_HUMANDCBD2_HUMANBioGRID, IntAct32296183 details
GDAP1_HUMANNXP20_HUMANBioGRID, IntAct32296183 details
GDAP1_HUMANLIPR1_HUMANBioGRID, IntAct32296183 details
GDAP1_HUMANTM14B_HUMANBioGRID, IntAct32296183 details
GDAP1_HUMANABHGA_HUMANBioGRID, IntAct32296183 details
GDAP1_HUMANAPOD_HUMANBioGRID, IntAct32296183 details
GDAP1_HUMANSTAR4_HUMANBioGRID, IntAct32296183 details
GDAP1_HUMANTM218_HUMANBioGRID, IntAct32296183 details
GDAP1_HUMANCLCN7_HUMANBioGRID, IntAct32296183 details
GDAP1_HUMANSNX2_HUMANIntAct32814053 details
GDAP1_HUMANSMN_HUMANIntAct32814053 details
GDAP1_HUMANP85A_HUMANIntAct32814053 details
GDAP1_HUMANMSH5_HUMANIntAct32814053 details
GDAP1_HUMANHXC4_HUMANIntAct32814053 details
GDAP1_HUMANBOK_HUMANIntAct32814053 details
GDAP1_HUMANBIRC5_HUMANIntAct32814053 details
GDAP1_HUMANM3K5_HUMANIntAct32814053 details
GDAP1_HUMANSPT12_HUMANIntAct32814053 details
GDAP1_HUMANKRA81_HUMANIntAct32814053 details
GDAP1_HUMANFOXR1_HUMANIntAct32814053 details
GDAP1_HUMANIQUB_HUMANIntAct32814053 details
GDAP1_HUMANVP37A_HUMANIntAct32814053 details
GDAP1_HUMANMOFA1_HUMANIntAct32814053 details
GDAP1_HUMANZN697_HUMANIntAct32814053 details
GDAP1_HUMANHUMMR_HUMANIntAct32814053 details
GDAP1_HUMANWDR61_HUMANIntAct32814053 details
GDAP1_HUMANDAZ3_HUMANIntAct32814053 details
GDAP1_HUMANCEP55_HUMANIntAct32814053 details
GDAP1_HUMANEVL_HUMANIntAct32814053 details
GDAP1_HUMANSCAPE_HUMANIntAct32814053 details
GDAP1_HUMANAAMDC_HUMANIntAct32814053 details
GDAP1_HUMANZN638_HUMANIntAct32814053 details
GDAP1_HUMANZDH17_HUMANIntAct32814053 details
GDAP1_HUMANDDX20_HUMANIntAct32814053 details
GDAP1_HUMANBAIP2_HUMANIntAct32814053 details
GDAP1_HUMANOPTN_HUMANIntAct32814053 details
GDAP1_HUMANIQEC1_HUMANIntAct32814053 details
GDAP1_HUMANTAGL2_HUMANIntAct32814053 details
GDAP1_HUMANCLPP_HUMANIntAct32814053 details
GDAP1_HUMANATX3_HUMANIntAct32814053 details
GDAP1_HUMANTBB5_HUMANBioGRID21890626 details
GDAP1_HUMANFIS1_HUMANBioGRID21890626 details